These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1546727)

  • 1. Estrogen and the risk of coagulopathy.
    Lobo RA
    Am J Med; 1992 Mar; 92(3):283-5. PubMed ID: 1546727
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of venous thrombosis with hormone replacement therapy.
    Scarabin PY
    Lancet; 1996 Dec; 348(9042):1668. PubMed ID: 8962022
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of venous thrombosis with hormone-replacement therapy.
    Vandenbroucke JP; Helmerhorst FM
    Lancet; 1996 Oct; 348(9033):972. PubMed ID: 8855846
    [No Abstract]   [Full Text] [Related]  

  • 4. Case-control study of venous thromboembolism risk in users of hormone replacement therapy.
    Daly E; Vessey MP; Painter R; Hawkins MM
    Lancet; 1996 Oct; 348(9033):1027. PubMed ID: 8855869
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy is not a risk for venous thrombosis.
    Forbes CD; Greer IA
    Scott Med J; 1994 Dec; 39(6):165-6. PubMed ID: 8778977
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement therapy and endometrial cancer: are current regimens safe?
    Grady D; Ernster VL
    J Natl Cancer Inst; 1997 Aug; 89(15):1088-9. PubMed ID: 9262240
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of venous thrombosis with hormone replacement therapy.
    McKenna MJ
    Lancet; 1996 Dec; 348(9042):1668. PubMed ID: 8962021
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen replacement therapy is not conducive of venous thromboembolism.
    Young RL; Goepfert AR; Goldzieher HW
    Maturitas; 1991 Sep; 13(3):189-92. PubMed ID: 1943826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patch instead of pill: a safer menopausal estrogen?
    Cushman M
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dermatoses caused by estrogens and progesterone: an upcoming nosology].
    Estève E
    Ann Dermatol Venereol; 1998 Aug; 125(8):484-5. PubMed ID: 9747310
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk of venous thrombosis during postmenopausal estrogen therapy? The reporting system of adverse effects is functioning].
    Buajordet I; Dybwad TB
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2644-5. PubMed ID: 9324824
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risk of venous thromboembolism during postmenopausal hormone therapy].
    Pedersen AT; Ottesen B
    Ugeskr Laeger; 1996 Nov; 158(48):6923-4. PubMed ID: 8984757
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
    Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
    Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41).
    Med Lett Drugs Ther; 2012 Jul; 54(1394):56. PubMed ID: 22826825
    [No Abstract]   [Full Text] [Related]  

  • 18. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 19. Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.
    Kaunitz AM
    Menopause; 2012 Jun; 19(6):602-3. PubMed ID: 22549171
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone therapy: making decisions in the face of uncertainty.
    Peterson HB; Thacker SB; Corso PS; Marchbanks PA; Koplan JP
    Arch Intern Med; 2004 Nov; 164(21):2308-12. PubMed ID: 15557408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.